PDB Short entry for 2RLF HEADER PROTON TRANSPORT 11-JUL-07 2RLF TITLE PROTON CHANNEL M2 FROM INFLUENZA A IN COMPLEX WITH INHIBITOR TITLE 2 RIMANTADINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: MATRIX PROTEIN 2; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: RESIDUES 18-60; COMPND 5 SYNONYM: PROTON CHANNEL PROTEIN M2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: INFLUENZA A VIRUS (A/UDORN/307/1972(H3N2)); SOURCE 3 ORGANISM_TAXID: 381517; SOURCE 4 STRAIN: A/UDORN/307/1972 H3N2; SOURCE 5 GENE: M; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: VECTOR; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PMMHB KEYWDS M2, PROTON CHANNEL, RIMANTADINE, PROTON TRANSPORT EXPDTA SOLUTION NMR NUMMDL 15 AUTHOR J.J.CHOU,J.R.SCHNELL REVDAT 4 10-NOV-21 2RLF 1 REMARK SEQADV REVDAT 3 10-MAR-09 2RLF 1 JRNL REVDAT 2 24-FEB-09 2RLF 1 VERSN REVDAT 1 29-JAN-08 2RLF 0 JRNL AUTH J.R.SCHNELL,J.J.CHOU JRNL TITL STRUCTURE AND MECHANISM OF THE M2 PROTON CHANNEL OF JRNL TITL 2 INFLUENZA A VIRUS. JRNL REF NATURE V. 451 591 2008 JRNL REFN ISSN 0028-0836 JRNL PMID 18235503 JRNL DOI 10.1038/NATURE06531 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NMRPIPE 3.0, X-PLOR NIH 2.17.0 REMARK 3 AUTHORS : DELAGLIO, GRZESIEK, VUISTER, ZHU, PFEIFER AND BAX REMARK 3 (NMRPIPE), SCHWIETERS, KUSZEWSKI, TJANDRA, CLORE REMARK 3 (X-PLOR NIH) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2RLF COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 19-JUL-07. REMARK 100 THE DEPOSITION ID IS D_1000150001. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303.1 REMARK 210 PH : 7.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.75MM [U-100% 15N] PROTEIN, REMARK 210 40MM PHOSPHATE, 30MM GLUTAMATE, REMARK 210 40MM RIMANTADINE, 250MM REMARK 210 DIHEXANOYLPHOSPHOCHOLINE, 93% REMARK 210 H2O/7% D2O; 0.75MM [U-100% 13C; REMARK 210 U-100% 15N] PROTEIN, 40MM REMARK 210 PHOSPHATE, 30MM GLUTAMATE, 40MM REMARK 210 RIMANTADINE, 250MM REMARK 210 DIHEXANOYLPHOSPHOCHOLINE, 93% REMARK 210 H2O/7% D2O; 0.75MM [U-100% 15N] REMARK 210 PROTEIN, 40MM PHOSPHATE, 30MM REMARK 210 GLUTAMATE, 40MM RIMANTADINE, REMARK 210 250MM [U-100% 2H] REMARK 210 DIHEXANOYLPHOSPHOCHOLINE, 93% REMARK 210 H2O/7% D2O; 0.75MM [U-100% 13C; REMARK 210 U-100% 15N] PROTEIN, 40MM REMARK 210 PHOSPHATE, 30MM GLUTAMATE, 40MM REMARK 210 RIMANTADINE, 250MM [U-100% 2H] REMARK 210 DIHEXANOYLPHOSPHOCHOLINE, 93% REMARK 210 H2O/7% D2O; 0.75 MM [U-100% 13C; REMARK 210 U-100% 15N; 80% 2H] ENTITY, 40 REMARK 210 MM PHOSPHATE, 30 MM GLUTAMATE, REMARK 210 40 MM RIMANTADINE, 250 MM REMARK 210 DIHEXANOYLPHOSPHOCHOLINE, 93% REMARK 210 H2O/7% D2O; 0.75MM [U-15N; U-2H] REMARK 210 PROTEIN, 40MM PHOSPHATE, 30MM REMARK 210 GLUTAMATE, 40MM RIMANTADINE, REMARK 210 250MM [U-100% 2H] REMARK 210 DIHEXANOYLPHOSPHOCHOLINE, 93% REMARK 210 H2O/7% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HNCA; 3D REMARK 210 HNCACB; 3D 1H-15N NOESY; 3D 1H- REMARK 210 13C NOESY; J(NCGAMMA-ALIPHATIC); REMARK 210 J(NCGAMMA-AROMATIC); J(METHYL-NH) REMARK 210 ; J(METHYL-CO); J(METHYL-CA); REMARK 210 INTERLEAVED TROSY + HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 500 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 3.0, CARA 1.8, X-PLOR REMARK 210 NIH 2.17.0, MOLMOL 2K.2 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 150 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 15 REMARK 210 CONFORMERS, SELECTION CRITERIA : OVERALL ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-15 REMARK 465 RES C SSSEQI REMARK 465 ARG A 18 REMARK 465 SER A 19 REMARK 465 ASN A 20 REMARK 465 ASP A 21 REMARK 465 SER A 22 REMARK 465 ARG B 18 REMARK 465 SER B 19 REMARK 465 ASN B 20 REMARK 465 ASP B 21 REMARK 465 SER B 22 REMARK 465 ARG C 18 REMARK 465 SER C 19 REMARK 465 ASN C 20 REMARK 465 ASP C 21 REMARK 465 SER C 22 REMARK 465 ARG D 18 REMARK 465 SER D 19 REMARK 465 ASN D 20 REMARK 465 ASP D 21 REMARK 465 SER D 22 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HH21 ARG C 45 HNC2 RIM B 299 1.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PHE A 48 94.52 -50.23 REMARK 500 1 LYS A 49 -82.43 -91.65 REMARK 500 1 ASP B 24 51.23 -157.72 REMARK 500 1 PHE B 48 3.91 -171.15 REMARK 500 1 LYS B 49 -142.06 -71.89 REMARK 500 1 SER B 50 75.74 51.54 REMARK 500 1 LEU B 59 82.45 -66.35 REMARK 500 1 PRO C 25 -11.41 -45.22 REMARK 500 1 LEU C 46 -34.95 -31.00 REMARK 500 1 PHE C 47 102.04 68.20 REMARK 500 1 LYS C 49 -150.14 -92.37 REMARK 500 1 SER C 50 92.97 47.06 REMARK 500 1 LEU C 59 -147.99 -85.24 REMARK 500 1 PHE D 48 155.20 -46.66 REMARK 500 1 LYS D 49 -146.45 64.23 REMARK 500 1 LEU D 59 -166.16 -63.10 REMARK 500 2 PHE A 48 97.74 75.96 REMARK 500 2 LYS A 49 -135.17 -150.23 REMARK 500 2 SER A 50 117.62 68.14 REMARK 500 2 PHE B 48 82.76 -173.41 REMARK 500 2 LYS B 49 -129.97 -141.80 REMARK 500 2 SER B 50 84.79 49.57 REMARK 500 2 PRO C 25 -8.57 -46.06 REMARK 500 2 PHE C 47 94.65 -59.07 REMARK 500 2 PHE C 48 6.99 -162.89 REMARK 500 2 PRO D 25 -10.45 -46.16 REMARK 500 2 PHE D 48 -153.86 -87.70 REMARK 500 2 LYS D 49 -62.81 74.14 REMARK 500 2 SER D 50 106.42 -53.85 REMARK 500 2 LEU D 59 77.61 -66.10 REMARK 500 3 ASP A 24 66.72 -152.40 REMARK 500 3 PRO A 25 -11.13 -45.82 REMARK 500 3 LEU A 46 -36.27 -31.30 REMARK 500 3 PHE A 47 -10.53 169.15 REMARK 500 3 PHE A 48 103.80 -46.21 REMARK 500 3 LYS A 49 -129.08 -145.44 REMARK 500 3 SER A 50 135.29 65.36 REMARK 500 3 PRO B 25 -9.65 -47.22 REMARK 500 3 LEU B 46 -35.90 -33.56 REMARK 500 3 PHE B 47 136.08 -172.59 REMARK 500 3 PHE B 48 98.58 -167.85 REMARK 500 3 LYS B 49 -35.73 -141.79 REMARK 500 3 ASP C 24 70.24 -171.11 REMARK 500 3 PRO C 25 -9.09 -48.53 REMARK 500 3 LEU C 38 -70.13 -63.09 REMARK 500 3 PHE C 47 -92.93 -47.23 REMARK 500 3 PHE C 48 19.63 46.09 REMARK 500 3 LYS C 49 -148.90 -64.01 REMARK 500 3 ASP D 24 160.11 -47.37 REMARK 500 3 PHE D 47 -170.40 -66.19 REMARK 500 REMARK 500 THIS ENTRY HAS 259 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RIM A 199 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RIM B 299 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RIM C 399 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RIM D 499 DBREF 2RLF A 18 60 UNP P63231 M2_IAUDO 18 60 DBREF 2RLF B 18 60 UNP P63231 M2_IAUDO 18 60 DBREF 2RLF C 18 60 UNP P63231 M2_IAUDO 18 60 DBREF 2RLF D 18 60 UNP P63231 M2_IAUDO 18 60 SEQADV 2RLF SER A 19 UNP P63231 CYS 19 ENGINEERED MUTATION SEQADV 2RLF SER A 50 UNP P63231 CYS 50 ENGINEERED MUTATION SEQADV 2RLF SER B 19 UNP P63231 CYS 19 ENGINEERED MUTATION SEQADV 2RLF SER B 50 UNP P63231 CYS 50 ENGINEERED MUTATION SEQADV 2RLF SER C 19 UNP P63231 CYS 19 ENGINEERED MUTATION SEQADV 2RLF SER C 50 UNP P63231 CYS 50 ENGINEERED MUTATION SEQADV 2RLF SER D 19 UNP P63231 CYS 19 ENGINEERED MUTATION SEQADV 2RLF SER D 50 UNP P63231 CYS 50 ENGINEERED MUTATION SEQRES 1 A 43 ARG SER ASN ASP SER SER ASP PRO LEU VAL VAL ALA ALA SEQRES 2 A 43 SER ILE ILE GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU SEQRES 3 A 43 ASP ARG LEU PHE PHE LYS SER ILE TYR ARG PHE PHE GLU SEQRES 4 A 43 HIS GLY LEU LYS SEQRES 1 B 43 ARG SER ASN ASP SER SER ASP PRO LEU VAL VAL ALA ALA SEQRES 2 B 43 SER ILE ILE GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU SEQRES 3 B 43 ASP ARG LEU PHE PHE LYS SER ILE TYR ARG PHE PHE GLU SEQRES 4 B 43 HIS GLY LEU LYS SEQRES 1 C 43 ARG SER ASN ASP SER SER ASP PRO LEU VAL VAL ALA ALA SEQRES 2 C 43 SER ILE ILE GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU SEQRES 3 C 43 ASP ARG LEU PHE PHE LYS SER ILE TYR ARG PHE PHE GLU SEQRES 4 C 43 HIS GLY LEU LYS SEQRES 1 D 43 ARG SER ASN ASP SER SER ASP PRO LEU VAL VAL ALA ALA SEQRES 2 D 43 SER ILE ILE GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU SEQRES 3 D 43 ASP ARG LEU PHE PHE LYS SER ILE TYR ARG PHE PHE GLU SEQRES 4 D 43 HIS GLY LEU LYS HET RIM A 199 34 HET RIM B 299 34 HET RIM C 399 34 HET RIM D 499 34 HETNAM RIM RIMANTADINE HETSYN RIM 1-(1-ADAMANTYL)ETHANAMINE FORMUL 5 RIM 4(C12 H21 N) HELIX 1 1 ASP A 24 PHE A 48 1 25 HELIX 2 2 ILE A 51 LEU A 59 1 9 HELIX 3 3 ASP B 24 LEU B 46 1 23 HELIX 4 4 ILE B 51 LEU B 59 1 9 HELIX 5 5 PRO C 25 LEU C 46 1 22 HELIX 6 6 ILE C 51 LEU C 59 1 9 HELIX 7 7 ASP D 24 LEU D 46 1 23 HELIX 8 8 ILE D 51 LEU D 59 1 9 SITE 1 AC1 2 ASP A 44 ARG B 45 SITE 1 AC2 4 LEU B 40 ASP B 44 TRP C 41 ARG C 45 SITE 1 AC3 4 LEU C 40 LEU C 43 ASP C 44 ARG D 45 SITE 1 AC4 3 ARG A 45 LEU D 40 ASP D 44 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000